JP2000504729A - カルジオトロフィンとその使用法 - Google Patents

カルジオトロフィンとその使用法

Info

Publication number
JP2000504729A
JP2000504729A JP9529601A JP52960197A JP2000504729A JP 2000504729 A JP2000504729 A JP 2000504729A JP 9529601 A JP9529601 A JP 9529601A JP 52960197 A JP52960197 A JP 52960197A JP 2000504729 A JP2000504729 A JP 2000504729A
Authority
JP
Japan
Prior art keywords
cells
dna
cell
sequence
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9529601A
Other languages
English (en)
Japanese (ja)
Inventor
ベイカー，ジョフレ
チェン，ケネス
キング，キャスリーン
ペニカ，ダイアン
ウッド，ウィリアム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California San Diego UCSD filed Critical University of California San Diego UCSD
Publication of JP2000504729A publication Critical patent/JP2000504729A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/175—Cardiotrophin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
JP9529601A 1996-02-14 1997-02-11 カルジオトロフィンとその使用法 Pending JP2000504729A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60139596A 1996-02-14 1996-02-14
US08/601,395 1996-02-14
PCT/US1997/002675 WO1997030146A2 (fr) 1996-02-14 1997-02-11 Cardiotrophine et ses utilisations

Publications (1)

Publication Number Publication Date
JP2000504729A true JP2000504729A (ja) 2000-04-18

Family

ID=24407322

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9529601A Pending JP2000504729A (ja) 1996-02-14 1997-02-11 カルジオトロフィンとその使用法

Country Status (6)

Country Link
EP (1) EP0885294A2 (fr)
JP (1) JP2000504729A (fr)
AU (1) AU733403B2 (fr)
IL (1) IL125548A (fr)
WO (1) WO1997030146A2 (fr)
ZA (1) ZA971226B (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008532490A (ja) * 2005-02-15 2008-08-21 アポロ ライフ サイエンシズ リミテッド 分子およびそのキメラ分子
JP2017147993A (ja) * 2016-02-25 2017-08-31 国立大学法人広島大学 始原生殖細胞の培養方法及び始原生殖細胞の培養用培地添加物
JP2023131904A (ja) * 2022-03-10 2023-09-22 国立大学法人愛媛大学 細胞の移植方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472585B1 (en) 1994-04-25 2002-10-29 Genentech, Inc. Cardiotrophin-1 defective mouse
US7258983B2 (en) 1994-04-25 2007-08-21 Genentech, Inc. Cardiotrophin-1 compositions and methods for the treatment of tumor
JP2002534987A (ja) * 1999-01-21 2002-10-22 ジェネンテック・インコーポレーテッド 腫瘍の治療のための組成物と方法
DK1697504T3 (da) 2003-11-26 2011-11-14 Merck Serono Sa Anvendelse af IL-6-type cytokiner til modning af oocytter
US9962427B2 (en) 2016-07-11 2018-05-08 Ottawa Hospital Research Institute Treatment of right ventricular dysfunction due to pressure overload

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995029237A1 (fr) * 1994-04-25 1995-11-02 Genentech, Inc. Cardiotrophine et ses utilisations

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008532490A (ja) * 2005-02-15 2008-08-21 アポロ ライフ サイエンシズ リミテッド 分子およびそのキメラ分子
JP2017147993A (ja) * 2016-02-25 2017-08-31 国立大学法人広島大学 始原生殖細胞の培養方法及び始原生殖細胞の培養用培地添加物
JP2023131904A (ja) * 2022-03-10 2023-09-22 国立大学法人愛媛大学 細胞の移植方法

Also Published As

Publication number Publication date
IL125548A0 (en) 1999-03-12
EP0885294A2 (fr) 1998-12-23
ZA971226B (en) 1998-08-13
WO1997030146A2 (fr) 1997-08-21
WO1997030146A3 (fr) 1997-10-09
IL125548A (en) 2004-07-25
AU733403B2 (en) 2001-05-10
AU1965497A (en) 1997-09-02

Similar Documents

Publication Publication Date Title
EP0755446B1 (fr) Cardiotrophine et ses utilisations
US5534615A (en) Cardiac hypertrophy factor and uses therefor
US5667780A (en) Antibodies to SMDF
US7105484B2 (en) GDNF receptorα
JP2002534957A (ja) 新規神経栄養性因子であるアルテミン
DE69930374T2 (de) Gfr-alpha3 und seine verwendungen
JPH10509717A (ja) 細胞連絡のモジュレーターとしてのニューレグリンの使用
JPH10507081A (ja) シュワン細胞の分離および培養
JP4086324B2 (ja) ニュールツリン受容体
JP2000504729A (ja) カルジオトロフィンとその使用法
JP4794049B2 (ja) 糖尿病治療へのＥｒｂＢレセプターリガンドの使用
KR100627754B1 (ko) Ｈｅｒ2 및(또는) ｈｅｒ3 수용체에 대한 리간드를 이용한내이 모 세포 증식의 향상 방법
US20040006018A1 (en) Cardiotrophin and uses therefor
DE69733414T2 (de) Protein tyrosin-phosphatasen von hematopoietischen zellen
AU768995B2 (en) Cardiotrophin and uses therefor
AU697165C (en) Cardiotrophin and uses therefor
CA2245635A1 (fr) Cardiotrophine et ses utilisations